PDCD1 and cervical adenocarcinoma: Cervical adenocarcinoma patients with PD-1 lymphocyte positivity had worse overall survival (p = 0.031, log-rank test, Fig. 2a) as well as worse progression-free survival (p = 0.087, log-rank test, Fig. 2a) compared with patients with PD-1 expression negativity.